Management is well aware of our concerns. They are hearing it directly from everyone.
They are not ignoring anyone either. Although they are wrong about their approach to date, I think you will see a slight change (at least I hope so).
I think after the AGM, the point was made clear to them that there are certain things they can release to keep us shareholders informed that will not tip off the competition…….their excuse so far. FYI, this is not just Hargrove as we all thought originally, it is Fowler too. I think the whole Titan team understands the need for better communication.
Actually my friend has been one of the biggest critics to date and he speaks to them directly. You are correct in that he feels the same way we do.
He specifically had conversations with them after the meeting and explained to them that somewhere is the range of 65% to 70% of their shareholders are retail investors. Of this large number, 90% or so don’t go to the company website or read a prospectus so they don’t know the company has started to work on the FDA applications…. He explained to them that all this information is clearly on the their web site and in the prospectus and that the competition probably has full time lawyers reviewing this information…so the people they most want to keep the information from are the most informed – aside from a group like us who shares such information.
Regarding the current shares taking a dump, he is cool as cucumber. It does not bother him – however let's be realistic, he much preferred the share price when it was trading at $2.70 per share versus $1.70 per share. He has been in Titan since day one so he understands what is going on and is now more pumped than ever. Although he already has a substantial position he said he is going to increase it more.
Summary, he liked $2.70 better than $1.70 but after the AGM and the discussions afterwards and after talking to Valvo, Hargrove and Fowler he is more confident than he ever was.
